Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$14.82 +3.6%	$15.61	$8.89 ▼ $24.50	$642.60M	N/A	487,151 shs	157,325 shs
BFLY Butterfly Network	$1.87 -0.3%	$2.17	$0.90 ▼ $4.98	$461.20M	2.46	3.25 million shs	1.48 million shs
KIDS OrthoPediatrics	$22.76 +4.0%	$21.58	$19.52 ▼ $34.77	$552.65M	1.1	196,508 shs	43,159 shs
LUCD Lucid Diagnostics	$1.12 +0.5%	$1.24	$0.72 ▼ $1.80	$120.63M	1.23	709,391 shs	238,506 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	+5.22%	+11.46%	-20.07%	+37.63%	+1,429,999,900.00%
BFLY Butterfly Network	+0.80%	+3.29%	-9.16%	-20.46%	+76.17%
KIDS OrthoPediatrics	-0.59%	-1.17%	+7.84%	+5.39%	-32.82%
LUCD Lucid Diagnostics	-0.89%	-5.13%	-11.90%	-13.28%	+32.17%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BFLY Butterfly Network	2.5594 of 5 stars	3.5	1.0	0.0	0.0	2.9	2.5	0.6
KIDS OrthoPediatrics	4.1299 of 5 stars	3.4	2.0	0.0	3.9	1.8	3.3	0.6
LUCD Lucid Diagnostics	2.5379 of 5 stars	3.6	2.0	0.0	0.0	2.3	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBNX Beta Bionics	2.75	Moderate Buy	$23.44	58.19% Upside
BFLY Butterfly Network	3.00	Buy	$3.50	86.77% Upside
KIDS OrthoPediatrics	2.86	Moderate Buy	$35.83	57.47% Upside
LUCD Lucid Diagnostics	3.20	Buy	$3.55	218.39% Upside

Current Analyst Ratings Breakdown

Latest LUCD, BFLY, KIDS, and BBNX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/16/2025	LUCD Lucid Diagnostics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$3.00
7/14/2025	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/1/2025	BFLY Butterfly Network	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$3.00
6/16/2025	BBNX Beta Bionics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$26.00
6/12/2025	BBNX Beta Bionics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$30.00
6/6/2025	LUCD Lucid Diagnostics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$7.50 ➝ $7.75
5/30/2025	BBNX Beta Bionics	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$16.00
5/30/2025	BBNX Beta Bionics	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$20.00
5/15/2025	LUCD Lucid Diagnostics	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$2.00 ➝ $2.00
5/14/2025	LUCD Lucid Diagnostics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$3.00 ➝ $3.00
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00

(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBNX Beta Bionics	$65.12M	9.87	N/A	N/A	($5.72) per share	-2.59
BFLY Butterfly Network	$82.06M	5.65	N/A	N/A	$0.79 per share	2.37
KIDS OrthoPediatrics	$212.45M	2.60	N/A	N/A	$14.64 per share	1.55
LUCD Lucid Diagnostics	$4.35M	27.73	N/A	N/A	($0.78) per share	-1.43

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBNX Beta Bionics	-$54.76M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
BFLY Butterfly Network	-$72.49M	-$0.29	N/A	N/A	N/A	-75.56%	-29.97%	-21.13%	8/1/2025 (Confirmed)
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)
LUCD Lucid Diagnostics	-$45.53M	-$1.34	N/A	N/A	N/A	-1,699.86%	N/A	-124.27%	8/11/2025 (Estimated)

Latest LUCD, BFLY, KIDS, and BBNX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2025	Q2 2025	LUCD Lucid Diagnostics	-$0.09	N/A	N/A	N/A	$1.15 million	N/A
8/4/2025	Q2 2025	KIDS OrthoPediatrics	-$0.17	N/A	N/A	N/A	$61.40 million	N/A
8/1/2025	Q2 2025	BFLY Butterfly Network	-$0.07	N/A	N/A	N/A	$23.91 million	N/A
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/6/2025	Q1 2025	BBNX Beta Bionics	-$0.51	-$0.52	-$0.01	-$0.93	N/A	N/A
5/2/2025	Q1 2025	BFLY Butterfly Network	-$0.09	-$0.06	+$0.03	-$0.06	$21.16 million	$21.23 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
LUCD Lucid Diagnostics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBNX Beta Bionics	N/A	15.88	14.93
BFLY Butterfly Network	N/A	6.06	4.43
KIDS OrthoPediatrics	0.21	6.19	2.99
LUCD Lucid Diagnostics	N/A	0.75	0.74

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBNX Beta Bionics	N/A
BFLY Butterfly Network	37.85%
KIDS OrthoPediatrics	69.05%
LUCD Lucid Diagnostics	74.01%

Insider Ownership

Company	Insider Ownership
BBNX Beta Bionics	N/A
BFLY Butterfly Network	25.18%
KIDS OrthoPediatrics	32.70%
LUCD Lucid Diagnostics	6.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBNX Beta Bionics	294	43.36 million	N/A	N/A
BFLY Butterfly Network	460	247.29 million	185.02 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.56 million	Optionable
LUCD Lucid Diagnostics	70	108.19 million	100.83 million	No Data

LUCD, BFLY, KIDS, and BBNX Headlines

Recent News About These Companies

Sargent Investment Group LLC Sells 498,000 Shares of Lucid Diagnostics Inc. (NASDAQ:LUCD)

July 21 at 7:34 AM | marketbeat.com

Lucid says meeting scheduled to determine Medicare coverage for cancer test

July 16, 2025 | msn.com

Lucid Diagnostics' (LUCD) Buy Rating Reaffirmed at Needham & Company LLC

July 16, 2025 | marketbeat.com

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test

July 16, 2025 | prnewswire.com

Brokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) Price Target at $3.55

July 16, 2025 | americanbankingnews.com

Lucid Diagnostics Inc News (LUCD) - Investing.com

July 11, 2025 | investing.com

Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Buy" from Analysts

July 11, 2025 | marketbeat.com

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

June 18, 2025 | prnewswire.com

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

May 27, 2025 | prnewswire.com

Lucid Diagnostics’ SWOT analysis: stock faces reimbursement hurdles amid market potential

May 21, 2025 | investing.com

Lucid Diagnostics Reports Increased Losses Amid Revenue Decline

May 15, 2025 | tipranks.com

Earnings call transcript: Lucid Diagnostics Q1 2025 highlights growth and strategic expansion

May 15, 2025 | investing.com

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

May 15, 2025 | prnewswire.com

Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript

May 14, 2025 | seekingalpha.com

Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates

May 14, 2025 | zacks.com

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

May 14, 2025 | prnewswire.com

Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know

May 7, 2025 | zacks.com

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

April 30, 2025 | prnewswire.com

Lucid Diagnostics’ EsoGuard DNA Test shows cancer detection efficacy in study

April 26, 2025 | markets.businessinsider.com

Lucid Diagnostics Reports Positive Data for EsoGuard in Study of Asymptomatic Patients

April 24, 2025 | theglobeandmail.com

Lucid reports encouraging results from EsoGuard study

April 24, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LUCD, BFLY, KIDS, and BBNX Company Descriptions

Beta Bionics NASDAQ:BBNX

$14.82 +0.52 (+3.64%)

As of 02:11 PM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Butterfly Network NYSE:BFLY

$1.87 -0.01 (-0.32%)

As of 02:40 PM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

OrthoPediatrics NASDAQ:KIDS

$22.76 +0.88 (+4.00%)

As of 02:40 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Lucid Diagnostics NASDAQ:LUCD

$1.12 +0.01 (+0.45%)

As of 02:40 PM Eastern

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time